A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

The researchers note that patients taking other types of HIV medications did not show the same reduction ... iVeena Delivery ...

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer’s disease after discovering that patients taking the drugs are substantially ...

Get Instant Summarized Text (Gist) Analysis of large health databases indicates that patients taking nucleoside reverse transcriptase inhibitors (NRTIs), drugs used for HIV and hepatitis B, have a ...

Now, researchers from UVA Health have uncovered a promising link between drugs initially developed for HIV and reduced Alzheimer's risk, highlighting an unexpected pathway for potential prevention.

This marks a shift in the agency's approach to treating the global obesity problem. Read more at straitstimes.com. Read more ...

UVA Health researchers say drugs used to treat HIV could help prevent a million new cases of Alzheimer’s each year – and they want clinical trials to find out. UVA’s Dr. Jayakrishna Ambati and his ...

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

The researchers note that patients taking other types of HIV medications did not show the ... Systems and Inflammasome Therapeutics; a full list of the authors’ disclosures is included in ...